Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 03-2006 | 12-2005 | 09-2005 | 06-2005 | 03-2005 | |
| Sales | 58 | 253 | 210 | 173 | 78 |
| Gross Profit | 58 | 253 | 210 | 173 | 78 |
| Operating Expenses | 5,991 | 4,366 | 3,644 | 2,979 | 1,745 |
| Operating Income | -5,934 | -4,113 | -3,434 | -2,805 | -1,668 |
| Other Income | 315 | 180 | -955 | 494 | 2,560 |
| Pre-tax Income | -5,619 | -3,933 | -4,389 | -2,311 | 893 |
| Net Income Continuous | -5,195 | -3,137 | -2,869 | -2,311 | 893 |
| Net Income Discontinuous | N/A | N/A | -74 | -655 | -277 |
| Net Income | $-5,195 | $-3,137 | $-2,943 | $-2,966 | $616 |
| EPS Basic Total Ops | -1.60 | -1.10 | -1.40 | -1.60 | 0.40 |
| EPS Basic Continuous Ops | -1.62 | -1.12 | -1.50 | -1.20 | 0.60 |
| EPS Basic Discontinuous Ops | N/A | N/A | 0.10 | -0.40 | -0.20 |
| EPS Diluted Total Ops | -1.60 | -1.10 | -1.30 | -1.60 | 0.30 |
| EPS Diluted Continuous Ops | -1.62 | -1.12 | -1.30 | -1.20 | 0.40 |
| EPS Diluted Discontinuous Ops | N/A | N/A | 0.10 | -0.40 | -0.20 |
| EBITDA(a) | $-5,757 | $-3,885 | $-3,196 | $-2,654 | $-1,520 |